Study finds overprescription of brand-name drugs in U.K. costs NHS $400 million per year DrugLogic introduces Qscan-RM drug safety tracking system FDA approves Humira for treatment of psoriasis Ranbaxy postpones demerger of drug discovery unit CollaGenex releases results of Oracea study Novartis reports major drop in Q4 profits Dr. Reddy's 'unlikely' to launch generic Plavix, Sanofi states Study shows statins ineffective against Alzheimer's DrugLogic adds two reporting programs to its offerings N.J. attorney general investigates Amgen over Enbrel accusations First Previous 2590 2591 2592 2593 2594 Next Last